Envirotainer has sold a 24.9 per cent stake in the company to Novo Holdings in partnership with the private equity firm Cinven.
Envirotainer chief executive officer, Michael Berg said: “We are pleased to welcome Novo Holdings as a partner alongside Cinven in Envirotainer, where we see great value from Novo Holdings healthcare expertise and pharmaceutical market knowledge to further develop the customer service offering of Envirotainer.”
Novo Holdings said it has identified Envirotainer as an attractive investment opportunity due to, amongst others its market leadership, the attractive market and global growth opportunity.
Novo Holdings senior director, Samir Kamal said, “Envirotainer is a very attractive investment opportunity for Novo Holdings. The company is a leading player and is in an excellent position to further benefit from the increasingly important demand for temperature controlled biopharma logistics.
“We are excited about this investment and look forward to, together with the management team and Cinven, be part of further developing Envirotainer.”
